Product ResearchHealthcareGenomics
Why HealthTech? Why HEAL?
The Global X HealthTech ETF (HEAL) seeks to provide exposure to companies driving healthcare's technological revolution.
A
Arelis Agosto
Apr 1, 20257 min read
Content loaded
Get the latest news and updates from our team.
SEI Investments Distribution Co. (1 Freedom Valley Drive, Oaks, PA, 19456) is the distributor for the Global X Funds.
Check the background of SIDCO and Global X's Registered Representatives on FINRA's BrokerCheck.
HealthTech ETF
GNOM seeks to invest in companies that stand to benefit from further advances in the field of genomic science, including those involved in gene editing, genomic sequencing, genetic medicine and therapy, computational genomics, and biotechnology.
AGNG seeks to provide exposure to companies positioned to serve the world's rapidly expanding senior population, spanning pharmaceuticals, biotechnology, and health care services that extend lifespans and enhance quality of life in advanced age.
EBIZ seeks to invest in companies positioned to benefit from the increased adoption of E-commerce as a distribution model, including those operating E-commerce platforms, providing E-commerce software and services, and selling goods and services online.
HEAL can complement traditional health care exposure by adding a more growth-oriented and global dimension to the allocation.
The fund provides access to emerging health care and technology-enabled businesses that may be underrepresented in broad U.S. health care allocations, while offering a way to express conviction in health care as a key beneficiary of AI and technology adoption.
The healthcare sector is under strain due to rising demand from an aging population and workforce shortages. Technology presents a viable solution, with the size of the HealthTech market expected to exceed $1T by 2032.1
The Fund invests in companies at the intersection of healthcare and technology across four key sub-themes: healthcare analytics and software, smart medical devices, AI drug discovery, and tech-enabled consumer healthcare.
A growing range of technologies are set to advance patient care, evidenced by increased AI device approvals, lower drug development costs and optimized administrative processes that are improving clinical workflows.
1Global X ETFs Forecasts, Mar 2025
Why HealthTech? Why HEAL?
The Global X HealthTech ETF (HEAL) seeks to provide exposure to companies driving healthcare's technological revolution.
Arelis Agosto
AI Applications in Healthcare: From Drug Discovery to Patient Care
Four Digital Health Companies Transforming the Healthcare Industry
The financial statements include the Fund's disclosures required by Items 7 through 11 of Form N-CSR, which includes the financial statements, financial highlights, and other important information when applicable.
The financial statements include the Fund's disclosures required by Items 7 through 11 of Form N-CSR, which includes the financial statements, financial highlights, and other important information when applicable.
AI is poised to render longstanding healthcare inefficiencies a thing of the past, potentially paving the way for lower costs and better care.
Arelis Agosto
Inefficiencies in the healthcare space could potentially create a large opportunity for companies using modern tech to cut costs and improve patient outcomes.
Arelis Agosto
As of Oct 16, 2026
Net Assets (%) | Ticker | Name | SEDOL | Market Price ($) | Shares Held | Market Value ($) |
|---|---|---|---|---|---|---|
| 6.50% | VEEV | VEEVA SYSTEMS INC-CLASS A | BFH3N85 | $310.36 | 6,519 | $2,023,237 |
| 6.07% | IQV | IQVIA HOLDINGS INC | BDR73G1 | $266.90 | 7,078 | $1,889,118 |
| 5.81% | OSCR |
Holdings are subject to change. "Cash" denotes U.S. dollars.
Overall rating out of 160 Health funds, based on risk-adjusted returns as of Sep 30, 2026.
Oct 16, 2026
30-Day SEC Yield
-0.17%
Distribution Frequency
Semi-Annually
Record Date | Payable Date | Amount | |
|---|---|---|---|
| Dec 30, 2026 | Dec 30, 2026 | Jan 7, 2027 | - |
Metric | 1 Year | 3 Year | 5 Year | Since Inception |
|---|---|---|---|---|
Fund NAV | -7.55% | +2.42% | -11.06% | -6.77% |
Market Price | -7.44% | +2.44% | -11.05% | -6.78% |
Index | -7.12% | +2.98% | -10.66% | -6.32% |
As of Oct 16, 2026
As of Oct 16, 2026
As of Oct 16, 2026
As of Oct 16, 2026
As of Sep 30, 2026
| Sector | Weight (%) |
|---|---|
Health Care | 92.31% |
Financials | 5.78% |
Consumer Staples | 1.91% |
| Sector | Weight (%) |
|---|---|
Health Care | 92.31% |
Financials | 5.78% |
Consumer Staples | 1.91% |
| Industry | Weight (%) |
|---|---|
Source: AltaVista Research, LLC
All Sector, Industry, Commodity and Geographic breakdowns, where provided, are based on equity positions held by the ETF and exclude cash, currencies, and other holdings.
As of Sep 30, 2026
The Global X HealthTech ETF (HEAL) invests in companies transforming healthcare through cutting-edge technology. The fund targets four sub-themes: AI-enabled drug discovery, smart medical devices, tech-enabled consumer healthcare, and healthcare analytics and software solutions. Companies in these areas harness advanced technologies to enhance patient care, streamline operations, and drive medical breakthroughs. By focusing on tech-driven innovation, HEAL seeks to provide exposure to firms shaping the future of healthcare.
The Global X HealthTech ETF (HEAL) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Global X HealthTech Index.
The Index is built to track firms positioned to benefit from further advances in the healthcare field. Its universe spans four interconnected sub-themes: healthcare analytics and software solutions, smart medical devices, AI-enabled drug discovery, and tech-enabled consumer healthcare. Eligibility is reserved for companies deriving at least 50% of revenues from these sub-themes, and the Index includes up to the top 40 such companies ranked by market capitalization.
Highlights
As of Oct 16, 2026
As of Oct 16, 2026
| OSCAR HEALTH INC - CLASS A |
| BKY83Q6 |
| $31.89 |
| 56,767 |
| $1,810,300 |
| 5.03% | DXCM | DEXCOM INC | B0796X4 | $86.04 | 18,201 | $1,566,014 |
| 4.47% | PME AU | PRO MEDICUS LTD | 6292782 | $122.41 | 11,363 | $1,390,989 |
| 4.23% | TEM | TEMPUS AI INC-CL A | BSLSJJ0 | $64.72 | 20,338 | $1,316,275 |
| 4.19% | RMD | RESMED INC | 2732903 | $238.97 | 5,455 | $1,303,581 |
| 4.09% | GEHC | GE HEALTHCARE TECHNOLOGY | BL6JPG8 | $69.57 | 18,295 | $1,272,783 |
| 3.80% | DEMANT DC | DEMANT A/S | BZ01RF1 | $54.02 | 21,900 | $1,182,946 |
| 3.78% | WAY | WAYSTAR HOLDING CORP | BSWYNW8 | $27.36 | 43,013 | $1,176,836 |
What is Premium/Discount Chart?
The Premium/Discount chart demonstrates the difference between the daily market price of shares of the Fund and the Fund's net asset value (NAV). The vertical axis of the chart shows the premium or discount of the daily market price as a percentage of the NAV. The horizontal axis shows each trading day in the time period, and each data point in the chart represents the Premium/Discount on that day. The data presented in the chart and table above represent past performance and cannot be used to predict future results.
How can the Fund trade at a premium/discount to its NAV?
The primary explanation is that timing discrepancies can arise between the NAV and the trading price of the Fund. Since shares of the Fund trade on the open market, prices are affected by the constant flow of information received by investors, corporations and financial institutions. Depending on how this changing information affects investor sentiment, shares of the Fund may deviate slightly from the value of the Fund's underlying assets. The NAV of the Fund is only calculated once a day (normally at 4:00 p.m. eastern time). As a result, shareholders may pay more than NAV when they buy Fund shares and receive less than NAV when they sell those shares, because shares are purchased and sold at current market prices. However, due to the creation and redemption process that is unique to ETFs, market makers are able to minimize these deviations from NAV by taking advantage of arbitrage opportunities.
What causes these time discrepancies?
Close of Trading Times. Although both the NAV and the daily market price of the Fund are generally calculated based on prices at the closing time of the exchange (generally 4:00 p.m. eastern time), slight differences in this timing may cause discrepancies.
Time of Last Trade. Trading of Global X funds generally takes place during normal trading hours (9:30 a.m. to 4:00 p.m. eastern time). However, it is important to note that the last trade - from which the closing price is determined - may not occur at exactly 4:00 p.m. eastern time. Therefore, changing market sentiment during the time difference may cause the NAV to deviate from the closing price.
International Holdings. The premiums and discounts for funds with significant holdings in international markets may be less accurate due to the different closing times of various international markets. Because the Funds trade during U.S. market hours while the underlying securities may not, the time lapse between the markets can result in differences between the NAV and the trading price.
Health Care Equipment & Services |
|---|
| 77.33% |
Pharmaceuticals, Biotechnology & Life Sciences | 14.94% |
|---|
Insurance | 5.81% |
|---|
Consumer Staples Distribution & Retail | 1.92% |
|---|
| Country | Weight (%) |
|---|---|
United States | 83.59% |
Australia | 5.68% |
Denmark | 3.42% |
Netherlands | 3.35% |
Hong Kong | 1.91% |
Britain | 1.04% |
South Korea | 0.52% |
Sweden | 0.49% |
As of Oct 16, 2026
Source: AltaVista Research, LLC